Veracyte: Rebecca Chambers
Veracyte has appointed Rebecca Chambers as executive VP and CFO. She will join the company July 19, reporting to Marc Stapley, Veracyte’s CEO. Chambers has extensive healthcare leadership experience, most recently serving as CFO for Outset Medical, a publicly traded medical technology company focused on reducing the cost and complexity of dialysis. Prior to that, she was with Illumina, where she served in a number of financial roles including VP of financial planning & analysis and VP of investor relations and treasury. Previously, Chambers served as head of investor relations and corporate communications at Myriad Genetics, and before that, she held various roles in investor relations at Life Technologies. She holds a BS from John Carroll University and an MBA from The S.C. Johnson Graduate School of Management at Cornell University.